ArticleMaterials (Basel, Switzerland)2026
Novel Antimicrobial Composites Modified with Nanosilver, CuSO
Article in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The antibiotic and drug resistance of various bacterial and fungal strains poses a significant challenge to medicine and industry. The subject of numerous studies is how to limit the spread of microorganisms and biofilm formation on various surfaces. This research focuses on the antibacterial and antifungal properties of cross-linked methacrylate-based composites for specific applications. These composites were modified using 10 wt.% of compounds with scientifically proven antimicrobial properties. These include nanosilver, copper sulphate, benzethonium chloride, and zinc oxide. The antimicrobial potential against the following bacteria and fungi was determined: Gram-positive bacteria (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.